Article PDF
References
Ministry of Health, Labor and Welfare of Japan : Kokumin Iryouhi No Doko. 2006 ( http://www.mhlw.go.jp/toukei/saikin/hw/k-iryohi/03/kekka1.html).
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group: Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981–2997 ( Erratum in: JAMA 2003; 289: 178 and JAMA 2004; 291: 2196).
Sakamaki Y, Sasamura H, Ikeda S, Ikegami N, Saruta T : Comparison of health associated with treatment of hypertension with a calcium channel blocker and angiotensin-converting enzyme inhibitor in the United States and Japan. Hypertens Res 2006; 29: 333–338.
Staessen JA, Li Y, Thijs L, Wang J-G : Blood pressure reduction and cardiovascular prevention: an update including the 2003–2004 secondary prevention trials. Hypertens Res 2005; 28: 385–407.
Nakamura K, Okamura T, Kanda H, et al: Impact of hypertension on medical economics; a 10-year follow-up study of National Health Insurance in Shiga, Japan. Hypertens Res 2005; 28: 859–864.
Okayama A, Kadowaki T, Okamura T, Hayakawa T, Ueshima H, on behalf of the NIPPON DATA80 Research Group: Age-specific effects of systolic and diastolic blood pressures on mortality due to cardiovascular diseases among Japanese men (NIPPON DATA80). J Hypertens 2006; 24: 459–462.
Ino Y, Hayashi M, Kawamura T, et al, Japanese Losartan Therapy Intended for the Global Renal Protection in Hypertensive Patients (JLIGHT) Study Investigators : Renoprotective effect of losartan in comparison to amlodipine in patients with chronic kidney disease and hypertension-a report of the Japanese Losartan Therapy Intended for the Global Renal Protection in Hypertensive Patients (JLIGHT) study. Hypertens Res 2004; 27: 21–30.
Yui Y, Sumiyoshi T, Kodama K, et al, JMIC-B Study Group: Comparison of nifedipine retard with angiotensin converting enzyme inhibitors in Japanese hypertensive patients with coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) randomized trial. Hypertens Res 2004; 27: 181–191.
Horita Y, Tadokoro M, Taura K, et al: Low-dose combination therapy with temocapril and losartan reduces proteinuria in normotensive patients with immunoglobulin a nephropathy. Hypertens Res 2004; 27: 963–970.
Fujikawa K, Hasebe N, Kikuchi K, NICE-Bombi Study Group: Cost-effectiveness analysis of hypertension treatment: controlled release nifedipine and candesartan low-dose combination therapy in patients with essential hypertension—the Nifedipine and Candesartan Combination (NICE-Combi) Study. Hypertens Res 2005; 28: 585–591.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ueshima, H. Differences in Medical Expenditure According to Drug Prices. Hypertens Res 29, 301–302 (2006). https://doi.org/10.1291/hypres.29.301
Received:
Issue Date:
DOI: https://doi.org/10.1291/hypres.29.301